DOI:
10.1055/s-00043364
Pharmaceutical Fronts
LinksClose Window
References
D'Incalci M, Galmarini CM.
A review of trabectedin (ET-743): a unique mechanism of action.
Mol Cancer Ther 2010;
9 (08) 2157-2163
We do not assume any responsibility for the contents of the web pages of other providers.